The Return on Investment of a Medicaid Tobacco Cessation Program in Massachusetts
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
BACKGROUND AND OBJECTIVE: A high proportion of low-income people insured by the Medicaid program smoke. Earlier research concerning a comprehensive tobacco cessation program implemented by the state of Massachusetts indicated that it was successful in reducing smoking prevalence and those who received tobacco cessation benefits had lower rates of in-patient admissions for cardiovascular conditions, including acute myocardial infarction, coronary atherosclerosis and non-specific chest pain. This study estimates the costs of the tobacco cessation benefit and the short-term Medicaid savings attributable to the aversion of inpatient hospitalization for cardiovascular conditions. METHODS: A cost-benefit analysis approach was used to estimate the program's return on investment. Administrative data were used to compute annual cost per participant. Data from the 2002-2008 Medical Expenditure Panel Survey and from the Behavioral Risk Factor Surveillance Surveys were used to estimate the costs of hospital inpatient admissions by Medicaid smokers. These were combined with earlier estimates of the rate of reduction in cardiovascular hospital admissions attributable to the tobacco cessation program to calculate the return on investment. FINDINGS: Administrative data indicated that program costs including pharmacotherapy, counseling and outreach costs about $183 per program participant (2010 $). We estimated inpatient savings per participant of $571 (range $549 to $583). Every $1 in program costs was associated with $3.12 (range $3.00 to $3.25) in medical savings, for a $2.12 (range $2.00 to $2.25) return on investment to the Medicaid program for every dollar spent. CONCLUSIONS: These results suggest that an investment in comprehensive tobacco cessation services may result in substantial savings for Medicaid programs. Further federal and state policy actions to promote and cover comprehensive tobacco cessation services in Medicaid may be a cost-effective approach to improve health outcomes for low-income populations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Tobacco control interventions10 42 43 overall reported a twofold ROIs, which increased when targeted at high-risk clients such as pregnant women.42”
From Return on investment of public health interventions: a systematic review (2017) · cites this paper as [43]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nicotine replacement therapy for smoking cessation
Stead, L. F., Perera, R., Bullen, C., Mant, D., Hartmann-Boyce, J., Cahill, K., & Lancaster, T. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000146.pub4 · Cited by 2,464
A framework for the study of access to medical care.
(1974) · PubMed Central · Cited by 2,419
Estimating log models: to transform or not to transform?
Manning, W. G., & Mullahy, J. (2001) · Journal of Health Economics · doi:10.1016/s0167-6296(01)00086-8 · Cited by 1,790 · cited 1×
“We used the diagnostic and specification tests recommended by Manning and Mullahy to select the final models [24].”
A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation
Jorenby, D. E., Leischow, S. J., Nides, M. A., Rennard, S. I., Johnston, J. A., Hughes, A. R., Smith, S. S., Muramoto, M. L., Daughton, D. M., Doan, K., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903043400903 · Cited by 1,585 · cited 1×
“Previous research has examined the efficacy of smoking cessation methods and found that pharmacotherapy can be a costeffective treatment modality [11–18].”
Tanoue, L. T. (2007) · Yearbook of Medicine · doi:10.1016/s0084-3873(08)70176-7 · Cited by 1,413
A Comparison of Alternative Models for the Demand for Medical Care
Duan, N., Manning, W. G., Morris, C. N., & Newhouse, J. P. (1983) · Journal of Business & Economic Statistics · doi:10.1080/07350015.1983.10509330 · Cited by 1,292 · cited 1×
“There are two well-recognized econometric problems in estimating medical expenditures. The first is that there are many zero observations leading to systematic differences in characteristics between patients with zero expenditure compared to those with positive expenditures. The second problem is that medical expendit…”
Vital signs: current cigarette smoking among adults aged >or=18 years --- United States, 2009.
Peachacek, T. F., Kaufmann, R. B., Caraballo, R. S., James, C., Regan, A. K., & Dube, S. R. (2010) · MMWR Morbidity and Mortality Weekly Report · Cited by 852
Too much ado about two-part models and transformation?
Buntin, M. B., & Zaslavsky, A. M. (2004) · Journal of Health Economics · doi:10.1016/j.jhealeco.2003.10.005 · Cited by 732 · cited 1×
“The second problem is that medical expenditures are highly skewed because a subset of patients with positive expenditures has very large expenditures [22–23].”
Cited by
Best Practices for Comprehensive Tobacco Control Programs
Control, D. (2014) · Cited by 620
Smoking, Mental Illness, and Public Health
Prochaska, J. J., Das, S., & Young-Wolff, K. C. (2017) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-031816-044618 · Cited by 503
“For example, Massachusetts saved more than $3 for every $1 spent on cessation services for state Medicaid program beneficiaries (103).”
BackgroundReturn on investment of public health interventions: a systematic review
Masters, R., Anwar, E., Collins, B., Cookson, R., & Capewell, S. (2017) · Journal of Epidemiology and Community Health · doi:10.1136/jech-2016-208141 · Cited by 480
Best practices for comprehensive tobacco control programs, 2014
King, B. A., Pechacek, T. F., & Mariolis, P. (2014) · Cited by 452
The Past, Present, and Future of Nicotine Addiction Therapy
Prochaska, J. J., & Benowitz, N. L. (2016) · Annual Review of Medicine · doi:10.1146/annurev-med-111314-033712 · Cited by 227
“Massachusetts saved more than $3 for every $1 spent on cessation services for state Medicaid program beneficiaries (94).”
BackgroundCurrent advances in research in treatment and recovery: Nicotine addiction
Prochaska, J. J., & Benowitz, N. L. (2019) · Science Advances · doi:10.1126/sciadv.aay9763 · Cited by 219
“In Massachusetts, for every $1 spent on cessation services for state Medicaid program beneficiaries, more than $3 was saved (190).”
BackgroundToll, B. A., Brandon, T. H., Gritz, E. R., Warren, G. W., & Herbst, R. S. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0666 · Cited by 205
“savings related to tobacco purchases, health, and insurance expenses (60) and secondary expenses such as costs of cleaning smoke residue from home, automobile, and clothes.”
BackgroundPharmacotherapy for smoking cessation: pharmacological principles and clinical practice
Aubin, H., Luquiens, A., & Berlin, I. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12116 · Cited by 138
“Despite the continuing debate over the legitimacy of using resources for individual smoking cessation instead of policy measures and interventions[11-14], the cost-effectiveness of smoking cessation programs has been consistently confirmed [15-17].”
BackgroundRealizing the Potential of Cancer Prevention — The Role of Implementation Science
Emmons, K. M., & Colditz, G. A. (2017) · New England Journal of Medicine · doi:10.1056/nejmsb1609101 · Cited by 127
Land, T., Warner, D., Paskowsky, M., Cammaerts, A., Wetherell, L., Kaufmann, R., Zhang, L., Malarcher, A., Pechacek, T., & Keithly, L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009770 · Cited by 119
Emmons, K. M., & Chambers, D. (2021) · Ethnicity & Disease · doi:10.18865/ed.31.1.133 · Cited by 127
Medicaid Tobacco Cessation: Big Gaps Remain In Efforts To Get Smokers To Quit
Ku, L. C., Bruen, B. K., Steinmetz, E., & Bysshe, T. (2016) · Health Affairs · doi:10.1377/hlthaff.2015.0756 · Cited by 98
Self-citationSingleterry, J., Jump, Z., DiGiulio, A., Babb, S. D., Sneegas, K. S., MacNeil, A., Zhang, L., & Williams, K.-A. S. (2015) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6442a3 · Cited by 70
A Cost Analysis for a Community-Based Case Management Intervention Program for Pediatric Asthma
Bhaumik, U., Norris, K., Charron, G., Walker, S. P., Sommer, S. J., Chan, E., Dickerson, D. U., Nethersole, S., & Woods, E. R. (2013) · Journal of Asthma · doi:10.3109/02770903.2013.765447 · Cited by 64
Koh, H. K., & Sebelius, K. G. (2012) · JAMA · doi:10.1001/jama.2012.9741 · Cited by 57
The Impact of Tobacco Dependence Treatment Coverage and Copayments in Medicaid
Greene, J., Sacks, R. M., & McMenamin, S. B. (2014) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2013.11.019 · Cited by 61
“84 per person.(14) Other studies have suggested more modest impacts of Medicaid TDT coverage.”
BackgroundSmoking prevalence in Medicaid has been declining at a negligible rate
Zhu, S., Anderson, C. M., Zhuang, Y.-L., Gamst, A. C., & Kohatsu, N. D. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178279 · Cited by 48
Emerging drugs for the treatment of tobacco dependence: 2014 update
Elrashidi, M. Y., & Ebbert, J. O. (2014) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2014.899580 · Cited by 46
“This abysmal investment in public health continues despite the potential benefit of generating $3 in healthcare cost savings for every $1 spent on comprehensive cessation efforts [10].”
BackgroundAuerbach, J. M. (2016) · Journal of Public Health Management and Practice · doi:10.1097/phh.0000000000000381 · Cited by 47
“30”
DiGiulio, A., Jump, Z., Yu, A., Babb, S. D., Schecter, A., Williams, K.-A. S., Yembra, D., & Armour, B. S. (2018) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6713a3 · Cited by 34
PUBLIC INSURANCE EXPANSIONS AND SMOKING CESSATION MEDICATIONS
Maclean, J. C., Pesko, M. F., & Hill, S. C. (2019) · Economic Inquiry · doi:10.1111/ecin.12794 · Cited by 34
DiGiulio, A., Jump, Z., Babb, S. D., Schecter, A., Williams, K.-A. S., Yembra, D., & Armour, B. S. (2020) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6906a2 · Cited by 34
Balogh, E. P., Dresler, C. M., Fleury, M. E., Gritz, E. R., Kean, T. J., Myers, M. L., Nass, S. J., Nevidjon, B., Toll, B. A., Warren, G. W., et al. (2013) · The Oncologist · doi:10.1634/theoncologist.2013-0230 · Cited by 35
DiGiulio, A., Haddix, M., Jump, Z., Babb, S. D., Schecter, A., Williams, K.-A. S., Asman, K., & Armour, B. S. (2016) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6548a2 · Cited by 31
“12 in medical savings occurred from averted cardiovascular hospitalizations alone (4).”
Herbst, N. P., Wiener, R. S., Helm, E. D., O’Donnell, C., Fitzgerald, C. A., Wong, C., Bulekova, K., Waite, M., Mishuris, R. G., & Kathuria, H. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.04.062 · Cited by 30
Guo, Y., Logan, H., Marks, J. G., & Shenkman, E. (2015) · Cancer Medicine · doi:10.1002/cam4.509 · Cited by 32
The Growing Proportion of Smokers in Medicaid and Implications for Public Policy
Zhu, S., Anderson, C. M., Wong, S., & Kohatsu, N. D. (2018) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2018.07.017 · Cited by 26
Ng, J. H., Ye, F., Roth, L., Sobel, K., Byron, S. C., Barton, M., Lindley, M. C., & Stokley, S. K. (2015) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6442a1 · Cited by 22
“Although this analysis is unable to identify reasons that HPV vaccination coverage by age 13 years for insured adolescents is low, studies have identified that clinicians are less likely to make a strong recommendation for HPV vaccination for adolescents aged 11 or 12 years compared with older adolescents (7,8).”
BackgroundMethodInvasive cancer incidence - United States, 2010.
Henley, S. J., Singh, S. D., King, J., Wilson, R. J., & Ryerson, A. B. (2014) · PubMed Central · Cited by 25
Bhaumik, U., Sommer, S. J., Giller-Leinwohl, J., Norris, K., Tsopelas, L., Nethersole, S., & Woods, E. R. (2016) · Journal of Asthma · doi:10.1080/02770903.2016.1201837 · Cited by 21
“An adjusted ROI was used to examinewhether the investmentsmade under CAI resulted in benefits that exceeded the investment cost and to determine the extent of the total return on investment from the CAI intervention over time [31].”
MethodA cost–benefit analysis of smoking cessation prescription coverage from a US payer perspective
Baker, C. L., Ding, Y., Ferrufino, C. P., Kowal, S. L., Tan, J., & Subedi, P. (2018) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s165576 · Cited by 24
“12 per $1 spent.(14) Our study expanded the scope of analysis from a state Medicaid program to a national study, lengthened the time horizon from 2 to 10 years, and included FDA-approved smoking cessation medications not included in the Massachusetts study, which were unavailable at the time of the study.”
InfluentialTong, E. K., STEWART, S. L., Schillinger, D., Vijayaraghavan, M., Dove, M. S., Epperson, A. E., Vela, C., Kratochvil, S., Anderson, C. M., Kirby, C. A., et al. (2018) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2018.07.031 · Cited by 21
“Previously, Massachusetts showed that broad promotion of a comprehensive Medicaid tobacco cessation benefit increased utilization of evidence-based services and reduced smoking prevalence.(13,14) New York City offered free nicotine medication through their quitline (2006−2010), and most of the enrolled 168,000 smokers…”
BackgroundKu, L. C., Brantley, E., Bysshe, T., Steinmetz, E., & Bruen, B. K. (2016) · Preventing Chronic Disease · doi:10.5888/pcd13.160234 · Cited by 20
Self-citationThe effectiveness of tobacco control policies on vulnerable populations in the USA: a review
Vijayaraghavan, M., Schroeder, S. A., & Kushel, M. (2016) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2014-133193 · Cited by 21
Costs of the Smoking Cessation Program in Brazil
Mendes, A. C. R., Toscano, C. M., Barcellos, R. M. D. S., Ribeiro, A. L. P., Ritzel, J. B., Cunha, V., & Duncan, B. B. (2016) · Revista de Saúde Pública · doi:10.1590/s1518-8787.2016050006303 · Cited by 49
Making a difference: Nursing scholarship and leadership in tobacco control
Sarna, L. P., Bialous, S. A., Chan, S. S. C., Hollen, P. J., & O’Connell, K. A. (2012) · Nursing Outlook · doi:10.1016/j.outlook.2012.05.007 · Cited by 19
Pharmacotherapies and harm-reduction options for the treatment of tobacco dependence
Houezec, J. L., & Aubin, H. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.818978 · Cited by 20
Policies Affecting Medicaid Beneficiaries’ Smoking Cessation Behaviors
Brantley, E., Greene, J., Bruen, B. K., Steinmetz, E., & Ku, L. C. (2018) · Nicotine & Tobacco Research · doi:10.1093/ntr/nty040 · Cited by 20
Self-citationLadapo, J. A., & Prochaska, J. J. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.04.067 · Cited by 17
“Some studies suggest that smoking cessation interventions have good value from a payor perspective and may be cost saving from a societal perspective (13,14).”
BackgroundMaclean, J. C., Pesko, M. F., & Hill, S. C. (2017) · National Bureau of Economic Research · doi:10.3386/w23450 · Cited by 17
Physicians’ Recommendations to Medicaid Patients About Tobacco Cessation
Holla, N., Brantley, E., & Ku, L. C. (2018) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2018.07.013 · Cited by 18
Self-citationProvider-Delivered Tobacco Dependence Treatment to Medicaid Smokers
Ferketich, A. K., Pennell, M. L., Seiber, E. E., Wang, L., Farietta, T., Jin, Y., & Wewers, M. E. (2014) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntt221 · Cited by 14
Verghese, C., Redko, C., & Fink, B. (2017) · Journal of Global Oncology · doi:10.1200/jgo.2017.1700016 · Cited by 14
“Even if initial implementation costs appear to be high, anti-smoking campaigns like those in Massachusetts have saved $3 in health care costs for every $1 spent implementing it.(20) In another study, Dilley et al(18) showed that between 2000 and 2009, for every dollar spent by the WashingtonState Tobacco Prevention an…”
BackgroundMossanen, M., Caldwell, J., Sonpavde, G., & Lehmann, L. S. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.18.00577 · Cited by 14
McCallum, D. M., Fosson, G. H., & Pisu, M. (2014) · Journal of Health Care for the Poor and Underserved · doi:10.1353/hpu.2014.0171 · Cited by 12
Reducing Tobacco-Related Cancer Incidence and Mortality: Workshop Summary
Forum, N. C. P., & Board on Health Care Services (2013) · National Academies Press eBooks · doi:10.17226/13495 · Cited by 21
“12 for every dollar spent in program costs (Richard et al., 2012).”
BackgroundHuskamp, H. A., Greenfield, S. F., Stuart, E. A., Donohue, J. M., Duckworth, K. S., Kouri, E. M., Song, Z., Chernew, M. E., & Barry, C. L. (2016) · Journal of General Internal Medicine · doi:10.1007/s11606-016-3718-y · Cited by 12
Naavaal, S., Malarcher, A. M., Xu, X., Zhang, L., & Babb, S. D. (2018) · Public Health Reports · doi:10.1177/0033354917753120 · Cited by 12
Silva, V. S. E., Moura, L. C., Leite, R. F., de Oliveira, P. C., Schirmer, J., & Roza, B. D. A. (2015) · Revista de Saúde Pública · doi:10.1590/s0034-8910.2015049005770 · Cited by 11
Roeseler, A. G., Solomon, M., Beatty, C., & Sipler, A. M. (2015) · Journal of Public Health Management and Practice · doi:10.1097/phh.0000000000000247 · Cited by 10
Saving lives efficiently across sectors: the need for a Congressional cost-effectiveness committee
Fitzpatrick, M. C., Singer, B. H., Hotez, P. J., & Galvani, A. P. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31440-x · Cited by 10
Barriers to Utilizing Medicaid Smoking Cessation Benefits
Knox, B. A., Mitchell, S., Hernly, E., Rose, A., Sheridan, H., & Ellerbeck, E. F. (2019) · Kansas Journal of Medicine · doi:10.17161/kjm.v10i4.8669 · Cited by 10
Cost-Effectiveness of a Comprehensive Primary Care Smoking Treatment Program
Mundt, M. P., McCarthy, D. E., Baker, T. B., Zehner, M. E., Zwaga, D., & Fiore, M. C. (2023) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2023.10.011 · Cited by 13
Sung, H., Penko, J. M., Cummins, S. E., Max, W. B., Zhu, S., Bibbins-Domingo, K. B., & Kohatsu, N. D. (2018) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2018.08.007 · Cited by 13
Herbst, R. S., Hatsukami, D. K., Acton, D., Giuliani, M., Moushey, A., Phillips, J., Sherwood, S., Toll, B. A., Viswanath, K., Warren, N. J. H., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-2429 · Cited by 13
Direct-to-Member Household or Targeted Mailings: Incentivizing Medicaid Calls for Quitline Services
Hood-Medland, E. A., Dove, M. S., STEWART, S. L., Cummins, S. E., Kirby, C. A., Vela, C., Kohatsu, N. D., & Tong, E. K. (2018) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2018.06.026 · Cited by 8
Beebe, L. A., Boeckman, L. M., Klein, P. G., Saul, J. E., & Gillaspy, S. R. (2019) · American Journal of Health Promotion · doi:10.1177/0890117119890789 · Cited by 8
Colorectal cancer screening: The costs and benefits of getting to 80% in every community
Green, B. B., & Meenan, R. T. (2020) · Cancer · doi:10.1002/cncr.32990 · Cited by 8
Jansen, A. L., Capesius, T. R., Lachter, R. B., Greenseid, L. O., & Keller, P. A. (2014) · BMC Health Services Research · doi:10.1186/s12913-014-0575-4 · Cited by 7
“Moreover, data demonstrate that treating tobacco use leads to higher patient satisfaction [4], improved patient health [5] and a positive return on investment [6], making treating tobacco use an ideal target for health care systems change efforts.”
BackgroundHerbst, R. S., Hatsukami, D. K., Acton, D., Giuliani, M., Moushey, A., Phillips, J., Sherwood, S., Toll, B. A., Viswanath, K., Warren, N. J. H., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.22.01749 · Cited by 10
Athar, H. M., Chen, Z., Contreary, K., Xu, X., Dube, S. R., & Chang, M. (2015) · Journal of Public Health Management and Practice · doi:10.1097/phh.0000000000000302 · Cited by 4
A Sustainable Smoking Cessation Program for Patients With Lung Cancer
Abrams, S. (2016) · Clinical journal of oncology nursing · doi:10.1188/16.cjon.e106-e111 · Cited by 4
Nonnemaker, J. M., MacMonegle, A. J., Mann, N., Woodlea, R., Duke, J. C., & Porter, L. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-040012 · Cited by 4
Sun, Y., Yu, X., Zhi, Y., Song, G., Li, H., Liu, T., Ke Cheng, X. U., & Qi, G. (2015) · Europe PMC (PubMed Central) · doi:10.6515/acs20150424a · Cited by 5
Eakin, M. N., Bauer, S. E., Carr, T., Dağlı, E., Ewart, G. W., Garfield, J. L., Jaspers, I., Kher, S., Leone, F. T., Melzer, A. C., et al. (2021) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202104-493ps · Cited by 4
Hilts, K. E., Blackburn, J. L., Gibson, P. J., Yeager, V. A., Halverson, P. K., & Menachemi, N. (2021) · Tobacco Prevention & Cessation · doi:10.18332/tpc/139812 · Cited by 3
Community Health Worker‐delivered tobacco cessation in a small rural county
Hahn, E. J., Bucher, A., Wiggins, A. T., Rademacher, K., Beckett, W., Taylor, L., Darville, A. K., & Edward, J. (2025) · The Journal of Rural Health · doi:10.1111/jrh.70017 · Cited by 2
Medicaid coverage for tobacco dependence treatment: Enrollee awareness and use
Hayes, K. A., Olson, L. T., Brown, E. M., Battles, H. B., & Juster, H. R. (2021) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2021.101509 · Cited by 2
A Framework for Effective Promotion of a Medicaid Tobacco Cessation Benefit
Williams, R. K., Brookes, R. L., & Singer, E. R. (2019) · Health Promotion Practice · doi:10.1177/1524839919829452 · Cited by 2
“12 return on investment to the Medicaid program during the period of 2007 to 2009 (Land, Rigotti, et al., 2010, Land, Warner, et al., 2010; Richard et al., 2012).”
BackgroundShahab, L., Lorrencatto, F., & Beard, E. (2013) · UCL Discovery (University College London) · Cited by 3
Prescription Smoking-Cessation Medication Fills and Spending, 2009–2019
Jackson, S. L., Tsipas, S., Yang, P. K., Ritchey, M. D., Loustalot, F. V., Wozniak, G., & Wang, X. (2022) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2021.11.021 · Cited by 1
McBrayer, C., Ouyang, F., Adams, Z. W., Hulvershorn, L. A., & Aalsma, M. C. (2022) · Tobacco Use Insights · doi:10.1177/1179173x221119133 · Cited by 1
Advancing Smoking Cessation in California's Medicaid Population
Roeseler, A. G., & Kohatsu, N. D. (2018) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2018.07.019 · Cited by 1
Flores, M. W., Mullin, B. O., Sharp, A., Kumar, A., Moyer, M., & Cook, B. L. (2023) · Journal of Racial and Ethnic Health Disparities · doi:10.1007/s40615-023-01558-w · Cited by 4
Richter, K. P., Shergina, E., Grodie, A., Massey, J. K., Ellerbeck, E. F., Applegate, A., & Faseru, B. (2018) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2018.03.006 · Cited by 1
Easy to reach, hard to replace: The value of brick-and-mortar poison centers
Olives, T. D., Leonard, J. B., Varney, S. M., & Gummin, D. D. (2026) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2026.02.026 · Cited by 1
The Effects of the Cigarette Excise Tax on State Smoking Rates, Healthcare Costs, and BeyondPreprint
Kushi, S. (2016) · SSRN Electronic Journal · doi:10.2139/ssrn.2718595
Abandono del hábito tabáquico tras un primer ingreso en el Servicio de Neumología
César, E. C., A, M. C. F., G, J. L. V., Marfil, N. R., L, L. L., S, M. C. V., Jiménez, L. P., & S, M. V. H. (2016) · Revista chilena de enfermedades respiratorias · doi:10.4067/s0717-73482016000100002
Ku, L. C., Steinmetz, E., Bysshe, T., & Bruen, B. K. (2017) · Public Health Reports · doi:10.1177/0033354917692954
Self-citationExpert Consensus Statements on Smoking Cessation Best Practice in Saudi Arabia
Amir, A., Babelli, O., Elhassan, A., Tobacco Control Program, M. O. H., Elnagib, A., Tobacco Control Program, M. O. H., & Turky, H. (2022) · Journal of Family Medicine · doi:10.26420/jfammed.2022.1284
El-Reshaid, K., & Al-Bader, A. (2023) · Clinical Case Reports Open Access · doi:10.46527/2582-5038.253
Nonnemaker, J. M., Mann, N., MacMonegle, A. J., Gaber, J., & Fajobi, O. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-080525
Chechulin, Y., Nanwa, N., Leddy, J. J., & Thompson, A. (2025) · Journal of Head Trauma Rehabilitation · doi:10.1097/htr.0000000000001055
Lessons from a medical student-run Public Health Journal Club- Survey study
Kroflin, K., Lužaić, K., Krstanović, K., Korać, B., & Milanović, S. M. (2025) · Archives of Public Health · doi:10.3889/aph.2025.6127
Hong, C., Han, S., Shang, J., Zhang, S., Zhao, M., Xia, C., Hao, T., Yao, Q., & Cai, W. (2026) · International Journal of Disaster Risk Science · doi:10.1007/s13753-026-00768-0
Metadata
- Authors
- Richard, P., West, K., & Ku, L.
- Affiliations
- George Washington University (US)
- Corresponding author
- Ku, Leighton
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-01-06
- Volume
- 7
- Issue
- 1
- Pages
- e29665
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3253087
- OpenAlex
- W2030668060
- Cited by
- 86
- References
- 31
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 1 · 2023: 3 · 2022: 5 · 2021: 5 · 2020: 3 · 2019: 5 · 2018: 12 · 2017: 7 · 2016: 13 · 2015: 9 · 2014: 8 · 2013: 7 · 2012: 2
- FWCI
- 5.58
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- George Washington University
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Keywords
- tobacco cessation programs, Medicaid, return on investment, cost-benefit analysis, cardiovascular hospitalization, smoking prevalence, low-income populations, smoking cessation pharmacotherapy, smoking cessation counseling, healthcare cost reduction, Massachusetts
- MeSH terms
- Adolescent, Adult, Algorithms, Cost-Benefit Analysis, Female, Hospitalization, Humans, Investments, Male, Massachusetts, Medicaid, Middle Aged, Smoking, United States, Health Care Costs, Tobacco Use Cessation, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
